Home|Journals|Articles by Year Follow on Twitter

Directory for Medical Articles
 

Open Access

Review Article

SRP. 2020; 11(3): 482-489


Conjugation of Sinapic Acid Analogues with 5-Fluorouracil: Synthesis, Preliminary Cytotoxicity, and Release Study

Yasser Fakri Mustafa, Mahmood Khudhayer Oglah, Moath Kahtan Bashir.

Abstract
Tripartite prodrug approach is a promising strategy to improve the therapeutic efficacy of orally administrated drugs having a low bioavailability. 5-Fluorouracil is a primary chemotherapeutic agent used in the treatment of many solid tumors. The oral use of 5-fluorouracil suffers from many challenges, which are principally contributed to the erratic activity of dihydropyrimidine dehydrogenase in the GIT. In this work, five integrates were prepared as tripartite mutual prodrugs by connecting sinapic acid and four of its analogues to 5-fluorouracil through amenable ester bond. Chemical structures of the prepared integrates were defined by studying their FTIR, 1H-NMR, and 13C-NMR spectra. Initiatory cytotoxicity study was verified for these integrates via MTT test versus four cancer cell lines including HeLa, MCF-7, AMN3, and SKG. The in vitro study of releasing the active drug from the synthesized integrates was followed spectrometerically using a human serum. The results of the cytotoxicity study after 24 hr of treatment revealed that the synthesized integrates by themselves have a non-toxic activity toward the test cell lines. In contrast, the results of the same study but after 72 hr of treatment indicated the potential antitumor activity of the tested prodrugs which indicates the effective release of the active components from these prodrugs. Also, the data gathered from the release study utilizing a human serum indicated that these integrates can release the active agents pursued pseudo first order kinetics. It is concluded that the synthesized integrates could be considered as mutual prodrugs and that may be improved the clinical applications of 5-Fluorouracil.

Key words: 5- Fluorouracil, Sinapic acid, Mutual prodrug, Antitumor, Release study, Kinetics.


Full-text options

Full-text Article




Advertisement
American Journal of Diagnostic Imaging

SUBMIT YOUR ARTICLE NOW




ScopeMed.com
BiblioMed Home
Follow ScopeMed on Twitter
Author Tools
eJPort Journal Hosting
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Database Service for Scientific Publications. Copyright ScopeMed Information Services.